微型细菌 spp. . . . . . . . . . . . . . . . . . . . . . 微型细菌 spp. . . . . . . . . . . . . . . . . 微型细菌 spp.
Xiao Yu1,2, Zhao Li1, Xinbo Yang2
1Department of Nephrology, Kidney Hospital, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Frontiers in medicine
|December 11, 2023
概括
腹膜透析相关腹膜炎 (PDRP) 是由微细菌spp引起的. 这是罕见的. 一个21天的抗生素治疗方案,结合万科米辛和美罗,显示出治疗PDRP的前景,治疗率很高.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 腹膜透析相关腹膜炎 (PDRP) 是由微细菌spp引起的. 是一种不常见的并发症.
- 只有9例Microbacterium spp. 的病例. 之前已经报告了PDRP.
- 这项研究详细介绍了7名患有Microbacterium spp.的患者的治疗经验. 这是一种PDRP.
研究的目的:
- 报告患有 Microbacterium spp. 的患者的治疗经验. 这是一种PDRP.
- 评估针对Microbacterium spp.的特定抗生素疗法的有效性. 这是一种PDRP.
- 将结果与之前报告的病例进行比较.
主要方法:
- 对7次由Microbacterium spp.引起的PDRP发作的临床数据和抗生素管理的回顾性收集.
- 审查关于Microbacterium spp.现有的文献. 这是一种PDRP.
- 经验和调整的抗生素治疗的分析,包括腹腔内 (IP) 健美素,万科米素和美罗.
主要成果:
- 经验性治疗包括IP gentamicin和vancomycin,如果 gentamicin无效,则将其切换为meropenem.
- 预期的抗生素疗程为21天.
- 在7次发作中,共有6次 (85.7%) 治愈,比之前报告的更高.
结论:
- 在21天的抗生素治疗中,将万科米辛和美罗胺结合起来,可能有助于控制Microbacterium spp. 这是一种PDRP.
- 这种治疗方法在研究的患者队列中显示出高治愈率.
- 进一步的研究可能会验证这种治疗方案用于罕见的PDRP病例.
相关概念视频
Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Microbiota of the Urogenital Tract
The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...


